| [1] |
上海市疾病预防控制中心．2007年上海市恶性肿瘤发病率．上海预防医学，2010，22(7): 400.
|
| [2] |
Xu J, Qin X, Wang J, et al. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol, 2011, 137(9): 1379-1396.
|
| [3] |
Kemeny N. Management of liver metastases from colorectal cancer. Oncology, 2006, 20(10): 1161-1179.
|
| [4] |
Sharma S, Camci C, Jabsbour N. Management of hepatic metastasis from colorectal cancers: an update. J Hepatobiliary Pancreat Surg, 2008, 15(6): 570-580.
|
| [5] |
Elias D, Youssef O, Sideris L, et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol, 2004, 86(1): 4-9.
|
| [6] |
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery alone for respectable liver metastases from colotectal cancer: a randomized controlled trial. Lancent, 2008, 371(9617): 1007-1016.
|
| [7] |
Chua TC, Saxena A, Liauw W, et al. Systematic review of radonmized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol, 2010, 17(2): 492-501.
|
| [8] |
Adam R, Bhangui P, Poston G, et al. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg, 2010, 252(5): 774-787.
|
| [9] |
Adam R, Avisar E, Ariche A. Five years survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal liver metastases. Ann Surg Oncol, 2001, 8(4): 347-353.
|
| [10] |
Moehler M, Hoffmann T, Zanke C, et al. Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer. Anticancer Drugs, 2003, 14(1): 79-85.
|
| [11] |
Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med, 2008, 359(17): 1757-1765.
|
| [12] |
Tsalis K, Vasiliadis K, Christoforidis E, et al. Current treatment of colorectal liver metastases. Tech Coloproctol, 2004, 8(Suppl 1): s174-176.
|
| [13] |
Kemeny MM, Adak SA, Gray B, et al. Combined-modality treatment for resectable metastatic colonrectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol, 2002, 20(6): 1499-1505.
|
| [14] |
Memon MA, Beckingham IJ. Surgical resection of colorectal liver metastases. Colorectal Dis, 2001, 3(6): 361-373.
|
| [15] |
Brouquet A, Mortenson MM, Vauthey JN, et al. Surgical strategies for synchronous colorectal liver metastasis in 156 consecutive patients: classic, combined or reverse strategy. J Am Coll Surg, 2010, 210(6): 934-941.
|
| [16] |
Perrine Goyer, Mehdi Karoui, LucaVigano, et al. Single-center multidisciplinary management of patients with colorectal cancer and resectable synchronous liver metastases improves outcomes. Clinics and Research in Hepatology and Gastroenterology, 2013, 37(1): 47-55.
|
| [17] |
Imamura H, Kawasaki S, Miyagawa S, et al. Aggressive surgical approach to recurrent tumors after hepatectomy for metastatic spread of colorectal cancer to the liver. Surgery, 2000, 127(5): 528-535.
|
| [18] |
Van der Pool AE, Méndez Romero A, Wunderink W, et al. Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg, 2010, 97(3): 377-382.
|
| [19] |
Engels B, Gevaert T, Everaert H, et al. Phase II study fo helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer. Radiation Oncology, 2012, 7: 34.
|
| [20] |
Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency alblation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Rdiology, 2001, 221(1): 159-166.
|
| [21] |
Ko S, Jo H, Yun S, et a1. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol, 2014, 20(2): 525-531.
|
| [22] |
Schullian P, Weiss H, Klaus A, et al. Laparoscopic liver packing to protext surrounding organs during thermal ablation. Minim Invasive Ther Allied Technol, 2014, 23(5): 294-301
|
| [23] |
Thanos L, Mylona S, Galani P, et al. Overcoming the heat-sink phenomenon: successful radiofrequency thermal ablation of liver tumors in contact with blood wessels. Diagn Interv Radiol, 2008, 14(1): 51-56.
|
| [24] |
Pathak S, Jones R, Tang JM, et al. Ablative therapies for colorectal liver metastases: Asystematic review. Colorectal Dis, 2011, 13(9): 252-265.
|
| [25] |
Mocellin S, Pilati P, Lise M, et al. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol, 2007, 25(35): 5649-5654.
|
| [26] |
Miyanari N, Mori T, Takahashi K, et al. Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer. Dis Colon Rectum, 2002, 45(11): 1503-1509.
|
| [27] |
李伟军，李劲松．无水酒精注射治疗结肠癌肝转移．浙江实用医学，2000，5(5): 29-30.
|
| [28] |
Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg, 1999, 86(2): 158.
|